Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Ancaman cacingan strongyloidiasis di Kalimantan Selatan: Kebiasaan warga bisa picu penyakit

● Infeksi cacing gelang Strongyloides stercoralis picu strongyloidiasis yang menyebabkan gangguan pencernaan, hingga kematian.● Selain strongyloidiasis, peneliti menemukan kasus cacingan l...

Bagaimana agar dana iklim global benar-benar mengalir sampai ke tapak

● Ada kesenjangan besar dalam pendanaan iklim Indonesia.● Mayoritas pendanaan iklim berasal dari luar APBN, tapi penyalurannya juga belum optimal.● Akses dan realisasi pendanaan ke t...

Hampir separuh masyarakat Indonesia tak mampu beli makanan sehat: Koreksi untuk sistem pangan kita

● Separuh warga Indonesia kesulitan membeli pangan sehat karena akses terbatas dan harga tinggi.● Sektor pertanian berfokus pada komoditas ekspor, bukan pangan sehari-hari.● Keterga...